recombinant NlpD protein (SelectImmune/University of Lund)

N/A

Report date: 2025/03/20 09:39:01

Base Information

Drug Namerecombinant NlpD protein (SelectImmune/University of Lund)
Drug Alias NameNlpD
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionRNA polymerase II modulators
TargetsRNA polymerase II
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelectImmune Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesHamlet BioPharma ABLund University
Inactive CompaniesSelectImmune Pharma AB
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A